Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
Abstract Phosphoenolpyruvate carboxykinase 1 (PEPCK1) is the critical enzyme for gluconeogenesis and is linked with type II diabetes. Previous studies have found that SIRT2, a deacetylase, plays an important role in deacetylating PEPCK1 and little is known about the anti-diabetic activity of SIRT2 i...
Guardado en:
Autores principales: | Mingming Zhang, Yida Pan, Robert G. Dorfman, Yuyao Yin, Qian Zhou, Shan Huang, Jie Liu, Shimin Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed6b75e32b7c475a94c7c22d11ce7103 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Pyrophosphate inhibits gluconeogenesis by restricting UDP-glucose formation in vivo
por: Ali Ferjani, et al.
Publicado: (2019) -
Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy
por: Weichen Wang, et al.
Publicado: (2021) -
O-GlcNAcylation of SIRT1 enhances its deacetylase activity and promotes cytoprotection under stress
por: Cuifang Han, et al.
Publicado: (2017) -
Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells.
por: Angela Orecchia, et al.
Publicado: (2011) -
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
por: Patrick L. Leslie, et al.
Publicado: (2019)